Our open source technology comes in the form of our bioinformatics toolkit which helps independent, government, and private researchers create meaningful and impactful CRISPR-Cas9 training sets for use in cancer research.

Our open source software exists under the Apache V2 License and we have a firm commitment to ensuring that effective cancer drugs can not be price gouged by massive corporate entities who get patents before others. Cancer treatments should follow a steadily decreasing plot similar to whole genome sequencing which was once $100 Million dollars for a single human genome. It is now around $150 USD.

Fill out our contact form on the main page and we will reach out when we begin beta testing of CPT-9, in the meantime you can start creating your .jsonl fine tuning data for specific types of cancer you may have sequences for.

We use NIH’s GRCh38 and also Tumor / Normal data derived from genomedata.org